The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma
1 other identifier
observational
363
1 country
1
Brief Summary
The purpose of the study is to investigate the prevalence of dysfunctional breathing in children and adolescents with asthma in a hospital outpatient clinic. Participants are invited to take the Nijmegen Questionnaire and the Asthma Control Questionnaire. The prevalence of dysfunctional breathing defined as NQ score \>= 23 is calculated, and demographics are compared between children with and without dysfunctional breathing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2021
CompletedFirst Posted
Study publicly available on registry
February 2, 2021
CompletedStudy Start
First participant enrolled
February 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedOctober 13, 2022
October 1, 2022
1.2 years
January 21, 2021
October 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of children with dysfunctional breathing defined as Nijmegen Questionnaire ( NQ) Score >= 23
Nijmegen Questionnaire is a 16 point questionnairre addressing dysfunctional breathing. Each question is scored from 0 (best) to 4 (worst). NQ score is summarized between 0-64 points. NQ score \>= 23 predicts dysfunctional breathing.
1 year
Secondary Outcomes (8)
Mask score
1 year
Asthma Control Questionnaire ( ACQ5)
1 year
Age
1 year
Sex
1 year
Standardised body mass index (BMI_SDS)
1 year
- +3 more secondary outcomes
Eligibility Criteria
Children and adolecents with asthma in a hospital outpatient clinic
You may qualify if:
- Asthma diagnosed by lung function tests and/or typical symptoms.
- Treatment with inhaled corticosteroids in minimum 3 months.
You may not qualify if:
- Other significant cardiopulmonary or muscoluskeletal conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kolding Sygehuslead
- Odense Patient Data Explorative Networkcollaborator
Study Sites (1)
Kolding Sygehus
Kolding, 6000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Signe Vahlkvist
Kolding Sygehus
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 21, 2021
First Posted
February 2, 2021
Study Start
February 5, 2021
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
October 13, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- Beginning 3 months and ending 5 years following article publication.
- Access Criteria
- Researchers who provide a methodologically sound proposal. Proposals should be directed to Open@rsyd.dk.
Individual participant data that underlie published results, after deidentification.